FDA Clears Sun Pharma's Halol Plant in India, an Industrial Info Market Brief

In a major decision for India's Sun Pharmaceutical Industries Limited, the U.S. Food and Drug Administration (FDA) cleared the company's export-oriented plant located in Halol in India's Gujarat state--a development that could significantly boost revenue for the Indian pharma major, as the plant alone contributes about 15% to the company's total volume of sales in the U.S. and has a share of nearly 25% in terms of profit it earns from the U.S. market. Industrial Info is tracking developments at 23 pharmaceutical plants owned by Sun Pharma globally. See map for locations.